
CHMX does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CHMX and 80,000+ other tickers.
See exactly how CHMX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CHMX and 80,000+ other tickers.
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation operates as a subsidiary of NEXT-ChemX Texas.